This holiday season, we celebrate “SixSEED Holiday Giving”, where each team member donates to an organization that is meaningful.
Cliff Kayser, MS, PCC: CSO
CLIFF KAYSER CONTRIBUTES TO SLOAN KETTERING INSTITUTE (SKI) For Cliff Kayser, he will contribute to Sloan Kettering Institute (SKI). Cliff explains why this is organization is important to him: “We all know someone challenged by a cancer diagnosis. One of my heroes, my sister Lori, has been living with a currently incurable cancer. The longer she follows the current protocols and takes good care of herself, her chances improve. Her hard work combined with scientific discoveries from experimental research is why I’m donating to the research arm of Memorial Sloan Kettering Cancer Center, “SKI” – the Sloan Kettering Institute. SKI was formed 70-years ago to fuel progress in cancer treatment by supporting scientific advances in the understanding of biology and medicine (such as: cancer-related genes, unraveled signaling pathways that control cell growth and division, and identified the cell types involved in mounting and repressing immune responses). SKI research has also been a driver of clinical advances in cancer treatment, from chemotherapy to targeted therapy to immunotherapy. I’ve had the pleasure of working with the amazing Leadership Training and Organization Development team at Memorial Sloan Kettering Cancer Center, and several team members became fully certified in PACT (Polarity Approach for Continuity and Transformation). It’s great knowing my colleagues are doing such great work to develop leaders there to accomplish their vision to harness the latest research techniques to conquer cancer.
ABOUT SLOAN KETTERING INSTITUTE (SKI):
In 1945, philanthropist Alfred P. Sloan, Jr., and engineer Charles F. Kettering founded the Sloan Kettering Institute (SKI) on New York City’s Upper East Side, with the vision of harnessing the latest research techniques in order to conquer cancer. This goal endures today. As the experimental research arm of Memorial Sloan Kettering Cancer Center, SKI is focused on the pursuit of fundamental scientific discoveries. The institute’s philosophy is that the best way to fuel progress in cancer treatment is to support scientists as they explore the unknown.
SKI is distinguished by its:
- world-renowned faculty
- cutting-edge technological resources
- relatively small size and open academic community
- extensive collaboration between scientists and clinicians
SKI exists as a distinct entity within the larger community of scholars, clinicians, and researchers that make up MSK. SKI hosts more than 100 laboratory investigators, 400 postdoctoral research fellows (including clinical fellows), and 300 PhD and MD/PhD graduate students. The institute enjoys a close relationship with neighbors Weill Cornell Medicine and The Rockefeller University.
Over the course of its 70-year history, SKI has produced many advances in our understanding of biology and medicine. SKI scientists have discovered cancer-related genes, unraveled signaling pathways that control cell growth and division, and identified the cell types involved in mounting and repressing immune responses. SKI research has also been a driver of clinical advances in cancer treatment, from chemotherapy to targeted therapy to immunotherapy.
SKI scientists are leaders in their fields. Many are members of the National Academies of Science and Medicine. Many are Howard Hughes Medical Institute investigators. They are the recipients of numerous awards and honors.
Leave a Reply